SecSonar.com

Nexalin Technology, Inc. (NXL)

Nexalin Technology, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Nexalin Technology, Inc. (NXL) is a Medical - Devices company based in US with a market capitalization of $11.9M. Revenue grew 78.8% year-over-year and free cash flow was negative at -$5M. This page tracks NXL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 6 employees · IPO Sep 16, 2022

Valuation

Valuation & price

$0.34 · as of May 17, 2026 · -81.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.18

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.86$1.09$0.32Jul 25Dec 25Jul 26Jul 7, 25$0.95Jul 9, 25$0.99Jul 11, 25$1.00Jul 15, 25$1.02Jul 17, 25$1.15Jul 21, 25$1.20Jul 23, 25$1.23Jul 25, 25$1.16Jul 29, 25$1.07Jul 31, 25$1.00Aug 4, 25$0.99Aug 6, 25$0.99Aug 11, 25$0.89Aug 13, 25$0.84Aug 15, 25$0.78Aug 19, 25$0.75Aug 21, 25$0.73Aug 25, 25$0.83Aug 27, 25$0.81Aug 29, 25$0.96Sep 3, 25$0.84Sep 5, 25$0.84Sep 9, 25$0.81Sep 11, 25$0.87Sep 16, 25$0.84Sep 18, 25$0.79Sep 22, 25$0.96Sep 24, 25$1.02Sep 26, 25$0.94Sep 30, 25$0.92Oct 2, 25$0.92Oct 6, 25$0.93Oct 8, 25$1.86Oct 10, 25$1.28Oct 14, 25$1.29Oct 16, 25$1.33Oct 21, 25$1.54Oct 23, 25$1.48Oct 27, 25$1.48Oct 29, 25$1.55Oct 31, 25$1.50Nov 4, 25$1.38Nov 6, 25$1.25Nov 10, 25$1.34Nov 12, 25$1.26Nov 14, 25$1.08Nov 18, 25$1.06Nov 20, 25$0.98Nov 25, 25$1.06Nov 28, 25$1.08Dec 2, 25$0.97Dec 4, 25$0.96Dec 8, 25$0.96Dec 10, 25$0.98Dec 12, 25$0.92Dec 16, 25$0.81Dec 18, 25$0.81Dec 22, 25$0.77Dec 24, 25$0.69Dec 29, 25$0.61Jan 2, 26$0.58Jan 6, 26$0.76Jan 8, 26$0.71Jan 12, 26$0.71Jan 14, 26$0.74Jan 16, 26$0.69Jan 21, 26$0.62Jan 23, 26$0.61Jan 27, 26$0.59Jan 29, 26$0.57Feb 2, 26$0.57Feb 4, 26$0.57Feb 9, 26$0.52Feb 11, 26$0.48Feb 13, 26$0.45Feb 18, 26$0.43Feb 20, 26$0.50Feb 24, 26$0.56Feb 26, 26$0.52Mar 2, 26$0.45Mar 4, 26$0.44Mar 6, 26$0.44Mar 10, 26$0.43Mar 12, 26$0.41Mar 17, 26$0.41Mar 19, 26$0.40Mar 23, 26$0.41Mar 25, 26$0.40Mar 27, 26$0.36Mar 31, 26$0.35Apr 2, 26$0.35Apr 7, 26$0.37Apr 9, 26$0.38Apr 13, 26$0.43Apr 15, 26$0.51Apr 17, 26$0.46Apr 22, 26$0.47Apr 24, 26$0.43Apr 28, 26$0.37Apr 30, 26$0.36May 4, 26$0.38May 6, 26$0.35May 8, 26$0.35May 12, 26$0.34May 14, 26$0.34May 18, 26$0.32May 20, 26$0.34May 22, 26$0.38May 28, 26$0.58Jun 1, 26$0.58Jun 3, 26$0.53Jun 5, 26$0.52Jun 9, 26$0.45Jun 11, 26$0.47Jun 15, 26$0.40Jun 17, 26$0.39Jun 22, 26$0.37Jun 24, 26$0.33Jun 26, 26$0.35Jul 2, 26$0.36
$0.3252-week range$1.86
Loading valuation history…

Fundamentals

Key fundamentals

$11.9M

Market cap

78.8%

Revenue growth (YoY)

79.7%

Gross margin

-$5M

Free cash flow (USD)

-$3.7M

Net debt

Net cash position

77.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$207.4KFY 2020$242.9KFY 2021$144.1KFY 2022$1.3MFY 2023$110.7KFY 2024$168.7KFY 2025$301.6K
$207.4K$301.6K

Free cash flow by year

2019 → 2025

FY 2019$-678.3KFY 2020$-864.1KFY 2021$-1.1MFY 2022$-2.2MFY 2023$-3.9MFY 2024$-3.9MFY 2025$-5.0M
-$678.3K-$5M

Gross margin by year

2021 → 2025

FY 202185.1%FY 202272.5%FY 202376.8%FY 202478.3%FY 202579.7%
85.1%79.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBylaws AmendedJun 17, 2026Filing
  • 8-K eventAcquisition AnnouncedMay 19, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventClinical Trial AgreementApr 22, 2026Filing

Questions

Frequently asked questions

What is Nexalin Technology, Inc.'s market cap?

Nexalin Technology, Inc. (NXL) has a market capitalization of $11.9M.

What is NXL's P/E ratio?

A meaningful P/E ratio is not available for NXL — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is NXL's price-to-book (P/B) ratio?

NXL trades at 3.18 times book value per share.

Are insiders buying NXL stock?

SEC Form 4 filings show no open-market insider buys at Nexalin Technology, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

LFWD

Lifeward Ltd.

$12.3M

ADGM

Adagio Medical Holdings, Inc.

$11.4M

CODX

Co-Diagnostics, Inc.

$9.5M

COCH

Envoy Medical, Inc.

$14.5M

ICCM

IceCure Medical Ltd

$14.7M

IRIX

IRIDEX Corporation

$17.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.